Zoetis Inc. ZTS | NYSE

$164.84 $1.32 | 0.81%

After Hours
$164.25 -$0.59 | -0.36%

Company Overview:

Market Cap: $74.37B
PE Ratio: 31.04
52-Week Range: $144.8 - $200.53
Dividend Yield (FWD): 1.21% ($2.00)

10 Year Performance Metrics:

Total Return (with DRIP): 307.32% (15.08% / yr)
Total Return (no DRIP): 299.59% (14.86% / yr)
Share Price: 279.73%
Dividend Increase: 420.48%
ZTS 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

ZTS Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
ZTS Dividend CAGR:1Y: 15.74%2Y: 15.47%5Y: 20.11%10Y: 19.67%
Share Price
ZTS Price CAGR:1Y: -15.31%2Y: 7.56%5Y: 4.44%10Y: 14.25%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

ZTS Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - ZTS
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - ZTS
14-Day FREE Trial Get Full Access Now!

ZTS Earnings, Revenue, Cash & Debt, Shares Outstaning:

ZTS - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
ZTS - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ZTS - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ZTS - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
ZTS - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
ZTS - Cash & Debt
14-Day FREE Trial Get Full Access Now!
ZTS - Revenue
14-Day FREE Trial Get Full Access Now!
ZTS Revenue CAGR:1Y: 11.02%2Y: 9.22%5Y: 8.56%10Y: 7.03%
ZTS - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
ZTS EPS CAGR:1Y: 16.28%2Y: 15.21%5Y: 10.76%10Y: 16.35%
ZTS - Net Income
14-Day FREE Trial Get Full Access Now!
ZTS Net Income CAGR:1Y: 14.43%2Y: 13.54%5Y: 9.51%10Y: 15.18%
ZTS - EBITDA
14-Day FREE Trial Get Full Access Now!
ZTS EBITDA CAGR:1Y: 27.23%2Y: 11.26%5Y: 9.07%10Y: 13.99%
ZTS - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
ZTS Free Cash Flow CAGR:1Y: 35.41%2Y: 45.17%5Y: 15.71%10Y: 29.09%
ZTS - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
ZTS Free Cash Flow / Share CAGR:1Y: 37.62%2Y: 47.54%5Y: 16.95%10Y: 30.41%
ZTS - Gross Profit
14-Day FREE Trial Get Full Access Now!
ZTS Gross Profit CAGR:1Y: 11.50%2Y: 9.97%5Y: 8.83%10Y: 8.08%
ZTS - Expenses
14-Day FREE Trial Get Full Access Now!
ZTS Expenses CAGR:1Y: 15.17%2Y: 4.14%5Y: 5.46%10Y: 14.80%
ZTS - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
ZTS Shares Outstanding CAGR:1Y: -1.71%2Y: -1.68%5Y: -1.19%10Y: -1.02%
ZTS - Share Buybacks
14-Day FREE Trial Get Full Access Now!
ZTS Share Buybacks CAGR:1Y: 73.20%2Y: 7.17%5Y: 23.62%10Y: N/A
ZTS - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
ZTS Stock-Based Comp CAGR:1Y: 5.88%2Y: 9.54%5Y: 2.38%10Y: 7.18%
ZTS - Dividends
14-Day FREE Trial Get Full Access Now!
ZTS Dividend CAGR:1Y: 15.74%2Y: 15.47%5Y: 20.11%10Y: 19.67%
ZTS - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
ZTS Revenue CAGR:1Y: 11.02%2Y: 9.22%5Y: 8.56%10Y: 7.03%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ZTS - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ZTS Actual Revenue CAGR:1Y: 11.02%2Y: 9.22%5Y: 8.56%10Y: 7.03%
ZTS - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ZTS Actual EPS CAGR:1Y: 16.28%2Y: 15.21%5Y: 10.76%10Y: 16.35%
ZTS - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ZTS Actual Net Income CAGR:1Y: 14.43%2Y: 13.54%5Y: 9.51%10Y: 15.18%
ZTS - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ZTS Actual EBITDA CAGR:1Y: 27.23%2Y: 11.26%5Y: 9.07%10Y: 13.99%

Ratios, Profit Margins & Return on Capital:

ZTS - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
ZTS Net Profit Margin CAGR:1Y: 3.07%2Y: 3.97%5Y: 0.88%10Y: 7.61%
ZTS - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
ZTS Gross Profit Margin CAGR:1Y: 0.43%2Y: 0.69%5Y: 0.25%10Y: 0.97%
ZTS - Price to Earnings
14-Day FREE Trial Get Full Access Now!
ZTS - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
ZTS - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
ZTS - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

ZTS Dividends Info:

Annual Dividend: $2.00
Forward Yield: 1.21%
Ex-Dividend Date: 2025-01-21
Lifetime Dividens / Share: $9.60

ZTS Dividend History: Dates, Payments & Yield list

Below is a schedule of all ZTS dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
01/21/202503/04/2025$0.5001.09%1.21%$164.84
10/31/202412/03/2024$0.4320.97%0.97%$178.78
07/18/202409/04/2024$0.4320.93%0.96%$179.23
04/18/202406/04/2024$0.4321.05%1.13%$153.11
01/18/202403/01/2024$0.4320.82%0.91%$190.50
10/31/202312/01/2023$0.3750.96%0.96%$157.00
07/20/202309/01/2023$0.3750.84%0.87%$171.61
04/20/202306/01/2023$0.3750.8%0.86%$174.40
01/19/202303/01/2023$0.3750.83%0.93%$161.95
10/31/202212/01/2022$0.3250.86%0.86%$150.78
07/20/202209/01/2022$0.3250.7%0.74%$176.25
04/20/202206/01/2022$0.3250.61%0.69%$187.78
01/19/202203/01/2022$0.3250.54%0.65%$200.58
10/28/202112/01/2021$0.2500.47%0.47%$212.67
07/20/202109/01/2021$0.2500.47%0.5%$200.11
04/20/202106/01/2021$0.2500.53%0.59%$168.74
01/19/202103/01/2021$0.2500.52%0.62%$162.57
10/20/202012/01/2020$0.2000.5%0.5%$159.69
07/16/202009/01/2020$0.2000.53%0.56%$142.94
04/16/202006/01/2020$0.2000.57%0.63%$127.45
01/16/202003/03/2020$0.2000.5%0.57%$139.24
10/21/201912/02/2019$0.1640.52%0.52%$126.45
07/18/201909/03/2019$0.1640.54%0.57%$114.94
04/17/201906/03/2019$0.1640.59%0.67%$97.98
01/17/201903/01/2019$0.1640.64%0.78%$84.25
11/19/201812/03/2018$0.1260.56%0.56%$90.10
07/19/201809/04/2018$0.1260.57%0.59%$85.42
04/19/201806/01/2018$0.1260.54%0.59%$85.41
01/18/201803/01/2018$0.1260.58%0.66%$76.33
11/08/201712/01/2017$0.1050.6%0.6%$69.51
06/13/201709/01/2017$0.1050.66%0.68%$61.96
04/04/201706/01/2017$0.1050.76%0.8%$52.65
01/18/201703/01/2017$0.1050.73%0.79%$53.30
11/01/201612/01/2016$0.0950.8%0.8%$47.25
06/28/201608/30/2016$0.0950.79%0.82%$46.42
04/05/201606/01/2016$0.0950.78%0.83%$45.85
01/19/201603/01/2016$0.0950.8%0.88%$43.19
11/03/201512/01/2015$0.0830.71%0.71%$46.63
08/11/201509/01/2015$0.0830.67%0.69%$48.21
04/07/201506/02/2015$0.0830.67%0.72%$46.36
01/20/201503/03/2015$0.0830.69%0.76%$43.56
11/03/201412/02/2014$0.0720.76%0.76%$37.72
08/18/201409/02/2014$0.0720.83%0.85%$33.93
04/24/201406/02/2014$0.0720.92%0.96%$29.89
01/28/201403/04/2014$0.0720.85%0.92%$31.44
10/30/201312/02/2013$0.0650.61%0.81%$32.06
07/30/201309/02/2013$0.0650.43%0.87%$30.04
04/29/201306/06/2013$0.0650.2%0.8%$32.66

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for ZTS

Based on past 10-year performance, here are ZTS growth metrics:

Share price CAGR of +14.27%
Dividend CAGR of +19.67%
Using ZTS CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

ZTS
Current Price$164.84
Start Shares60.66
Start Value$10,000
 
After 10 years:
Final Share Count69.08
Dividends Payment$2.60
Annual Dividends$719
Yield on cost7.19%
Share Price$547.76
Total Dividends$2,893
Final Value$37,841

Estimated Future Value + Dividends - ZTS

NOTE: Above numbers are our estimate based on ZTS's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Zoetis Inc. (ZTS) had its IPO on 2013-02-01, and is trader on NYSE stock exchange.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

ZTS website: https://www.zoetis.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial